ClinicalTrials.Veeva

Menu

Comparison of Robotic Arm-assisted PET/CT-guided Lung Biopsy With PET Fused CT- Fluoroscopy-guided Lung Biopsy

P

Post Graduate Institute of Medical Education and Research, Chandigarh

Status

Completed

Conditions

Lung Diseases
Lung Cancer
Adenocarcinoma of Lung

Treatments

Procedure: Robotic arm assisted PET/CT guided biopsy
Procedure: PET fused CT-Fluoroscopy guided biopsy

Study type

Observational

Funder types

Other

Identifiers

NCT05245630
NK/6832/MD/594

Details and patient eligibility

About

Patients with suspicious lung lesions were undertaken for PET/CT directed under CT fluoroscopy lung biopsy or robotic-assisted biopsy. The biopsy planning including patient positioning was done after F18-FDG PET/CT whole body or regional imaging of the patient. Written consent was obtained and the patient will be prepared for the biopsy. Lung biopsies were done using a semi-automatic biopsy gun under the imaging guidance (PET fused CT fluoroscopy) following aseptic precautions. Follow-up CT scans were taken post-biopsy. The time consumed for the procedure, radiation exposure to the interventionist, complications and diagnostic yield in both the arms were compared.

Full description

Patients with clinical suspicion of lung lesions were recruited for FDG PET/CT. Based on the PET/CT findings and clinical details a PET/CT guided biopsy was planned. The patients were assigned to the two arms. In the first arm, participants underwent a robotic-assisted biopsy. In the second arm, participants underwent PET/CT-directed CT fluoroscopy-guided lung biopsy. The biopsy planning including patient positioning was done after F18-FDG PET/CT whole body or regional imaging of the patient. Written consent was obtained and the patient will be prepared for the biopsy. Lung biopsies were done using a semi-automatic biopsy gun under the imaging guidance (PET fused CT fluoroscopy) following aseptic precautions. Follow-up CT scans were taken post-biopsy. The time consumed for the procedure, radiation exposure to the interventionist, complications and diagnostic yield in both the arms were compared.

Enrollment

59 patients

Sex

All

Ages

18 to 80 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  1. Age >/= 18 years
  2. FDG avid amenable lung lesion
  3. INR < 1.2 and Platelet counts > 80,000/mm3

Exclusion criteria

  1. Participants with pre-existing bleeding diathesis like hemophilia, coagulopathy defined by INR ≥ 1.2 and Platelet counts ≤ 80,000/mm3
  2. Participants who refuse to provide the written informed consent
  3. Signs of hypoperfusion like cyanosis, hypotension etc.
  4. Presence of hypoxemia (SpO2 < 95% -measured in a pulse oximeter)
  5. Pregnant/Lactating females participants
  6. Non-cooperative participants
  7. Inaccessible lesions (based on the decision made on pre-biopsy planning)
  8. CoVID-19 positive participants

Trial design

59 participants in 2 patient groups

Robotic arm assisted PET/CT guided biopsy
Description:
In this group, participants were recruited for robotic-assisted PET/CT guided biopsy from the FDG avid lung lesions. biopsies were done using an automated robotic arm (MAXIO-EX, Perfint healthcare Pvt Ltd, Chennai, India) to guide the needle for biopsy. It is a robotic arm with a four-ax guide arm and a planning console. Pre-interventional fused PET/CT images from Biograph mCT 16 scanner were sent via LAN cable to the device (MAXIO-EX) console.
Treatment:
Procedure: Robotic arm assisted PET/CT guided biopsy
Procedure: PET fused CT-Fluoroscopy guided biopsy
PET fused CT-Fluoroscopy guided biopsy
Description:
In this group, participants were recruited for PET fused CT-Fluoroscopy guided biopsy from the FDG avid lung lesions. A biopsy needle was placed to the target lesion on PET/CT under CT fluoroscopy
Treatment:
Procedure: Robotic arm assisted PET/CT guided biopsy
Procedure: PET fused CT-Fluoroscopy guided biopsy

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems